Literature DB >> 826950

Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.

H E Shannon, S G Holtzman.   

Abstract

The capacity of the specific narcotic antagonists naltrexone and naloxone to block the discriminative effects produced by morphine in the rat were evaluated using a two-choice, discrete-trial avoidance task. The antagonists produced a dose-dependent and time-dependent blockade of morphine's effects as measured by responding on the morphine-appropriate choice lever. Naltrexone and naloxone were equipotent when given subcutaneously concomitantly with subcutaneously administered morphine. However, when the antagonists were administered orally at 0, 2, 4 or 8 h prior to s.c. morphine, naltrexone was more potent than naloxone at every time point and had a duration of action at least twice that of oral naloxone. The discriminitive effects of the narcotic analgesics morphine and methadone were also compared after oral and subcutaneous administration. Both drugs produced dose-related discriminative effects and were one-tenth as potent by the oral as by the subcutaneous route of administration. These results suggest that the discriminative effects produced by morphine in the rat can provide an animal model for the quantitative evaluation of the narcotic antagonist properties of drugs that might be considered for use in narcotic antagonist maintenance programs for the treatment of narcotic addiction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826950     DOI: 10.1007/BF00430479

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Effect of loperamide, haloperidol and methadone in rats trained to discriminate morphine from saline.

Authors:  G Gianutsos; H Lal
Journal:  Psychopharmacologia       Date:  1975

2.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

3.  Morphine as a discriminative cue: effects of amine depletors and naloxone.

Authors:  J A Rosecrans; M H Goodloe; G J Bennett; I D Hirschhorn
Journal:  Eur J Pharmacol       Date:  1973-02       Impact factor: 4.432

4.  Morphine physical dependence in the dog.

Authors:  W R Martin; C G Eades; W O Thompson; J A Thompson; H G Flanary
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

5.  Naloxone treatment of opiate dependence. A progress report.

Authors:  A Zaks; T Jones; M Fink; A M Freedman
Journal:  JAMA       Date:  1971-03-29       Impact factor: 56.272

6.  Naloxone in heroin dependence.

Authors:  M Fink; A Zaks; R Sharoff; A Mora; A Bruner; S Levit; A M Freedman
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

Review 7.  The actions of narcotic antagonists in morphine-dependent rhesus monkeys.

Authors:  J E Villarreal; M G Karbowski
Journal:  Adv Biochem Psychopharmacol       Date:  1973

8.  Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum.

Authors:  H W Kosterlitz; A A Waterfield; V Berthoud
Journal:  Adv Biochem Psychopharmacol       Date:  1973

9.  An experimental study in the treatment of narcotic addicts with cyclazocine.

Authors:  W R Martin; C W Gorodetzky; T K McClane
Journal:  Clin Pharmacol Ther       Date:  1966 Jul-Aug       Impact factor: 6.875

10.  Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs.

Authors:  C A WINTER; L FLATAKER
Journal:  J Pharmacol Exp Ther       Date:  1950-03       Impact factor: 4.030

View more
  17 in total

1.  Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

Authors:  K W Locke; B Gorney; M Cornfeldt; S Fielding
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.

Authors:  Jason E Gallate; Paul E Mallet; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2003-12-09       Impact factor: 4.530

3.  Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

4.  Eating high-fat chow increases the sensitivity of rats to quinpirole-induced discriminative stimulus effects and yawning.

Authors:  Michelle G Baladi; Charles P France
Journal:  Behav Pharmacol       Date:  2010-10       Impact factor: 2.293

5.  Morphine as a discriminative cue in gerbils: drug generalization and antagonism.

Authors:  T U Järbe; C Rollenhagen
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

6.  Narcotic cuing and analgesic activity of narcotic analgesics: associative and dissociative characteristics.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

Review 7.  Drug discrimination by humans compared to nonhumans: current status and future directions.

Authors:  J B Kamien; W K Bickel; J R Hughes; S T Higgins; B J Smith
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

Authors:  N Joharchi; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat.

Authors:  W Koek; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of nimodipine on the discriminative stimulus properties of d-amphetamine in rats.

Authors:  P Nencini; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.